Market Access

Event Highlights for 13th Annual Industry Leading Cold Chain Distribution 2018

https://pharmaphorum.com/partner-content/event-highlights-for-13th-annual-industry-leading-cold-chain-distribution-2018/

Value-based healthcare: What’s it worth to you?

https://pharmaphorum.com/views-and-analysis/value-based-healthcare-whats-worth/

NICE in talks with Biogen after rejecting SMA drug

https://pharmaphorum.com/news/nice-in-talks-with-biogen-after-rejecting-sma-drug/

Breakthrough designation for Roche/Novartis’ Xolair in food allergies

https://pharmaphorum.com/news/breakthrough-designation-for-roche-novartis-xolair-in-food-allergies/

Amicus’ oral Fabry disease drug approved in US

https://pharmaphorum.com/news/amicus-oral-fabry-disease-drug-approved/

Astellas buys eye gene therapy biotech Quethera for $109m

https://pharmaphorum.com/news/astellas-expands-ocular-gene-therapy-investment/

Alnylam’s Onpattro is first ever FDA-approved RNAi drug

https://pharmaphorum.com/news/alnylams-onpattro-first-ever-approved-rnai-drug/

Sarepta dives deeper into gene therapy

https://pharmaphorum.com/news/sarepta-dives-deeper-gene-therapy/

CF patients furious as Vertex turns back on NICE

https://pharmaphorum.com/news/cf-patients-furious-as-vertex-turns-back-on-nice/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search